Squalamine Lactate Ophthalmic Solution, 0.2%
Squalamine Lactate Ophthalmic Solution, 0.2% is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
3
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
50.0%
2 of 4 finished
50.0%
2 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD
Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration
Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME)
Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion
Squalamine for the Treatment in Proliferative Diabetic Retinopathy
Clinical Trials (5)
Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD
Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration
Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME)
Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion
Squalamine for the Treatment in Proliferative Diabetic Retinopathy
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5